Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.

Newall, A T; Wood, J G; Chen, C; McIntyre, P; Beutels, P

Newall, A T; Wood, J G; Chen, C; McIntyre, P; Beutels, P.

Afiliação

Newall AT; School of Public Health and Community Medicine, UNSW Australia, Sydney, NSW, Australia. Electronic address: a.newall@unsw.edu.au.
Wood JG; School of Public Health and Community Medicine, UNSW Australia, Sydney, NSW, Australia.
Chen C; School of Public Health and Community Medicine, UNSW Australia, Sydney, NSW, Australia.
McIntyre P; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), Kids Research Institute, Children's Hospital at Westmead, NSW, Australia.
Beutels P; School of Public Health and Community Medicine, UNSW Australia, Sydney, NSW, Australia; Centre for Health Economics Research and Modelling Infectious Diseases (CHERM ID), Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.

Vaccine ; 37(52): 7534, 2019 12 10.

Article em En | MEDLINE | ID: mdl-31733945

Assuntos

Infecções Pneumocócicas; Austrália; Análise Custo-Benefício; Humanos; Polissacarídeos; Estudos Retrospectivos; Vacinação

Palavras-chave

Adult vaccination; Economic evaluation; Elderly; PPV23; Pneumococcal; Pneumonia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas Tipo de estudo: Evaluation_studies / Health_economic_evaluation / Observational_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Vaccine Ano de publicação: 2019 Tipo de documento: Article País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google